They found PSMA expression in 86.8% of HCCs and 79.3% of ICCs, but only 6.6% of liver cirrhosis cases, suggesting that PSMA overexpression may serve as a highly diagnostic marker for liver tumors. This evidence concerns the gene FOLH1 and cirrhosis of liver.